Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...

Descripción completa

Detalles Bibliográficos
Autores principales: Ylösmäki, Erkko, Malorzo, Cristina, Capasso, Cristian, Honkasalo, Oona, Fusciello, Manlio, Martins, Beatriz, Ylösmäki, Leena, Louna, Antti, Feola, Sara, Paavilainen, Henrik, Peltonen, Karita, Hukkanen, Veijo, Viitala, Tapani, Cerullo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127500/
https://www.ncbi.nlm.nih.gov/pubmed/30005865
http://dx.doi.org/10.1016/j.ymthe.2018.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127500/
https://www.ncbi.nlm.nih.gov/pubmed/30005865
http://dx.doi.org/10.1016/j.ymthe.2018.06.008

Ejemplares similares